ArticleTechnology in cancer research & treatment

The Influence of KDR Genetic Variation on the Efficacy and Safety of Patients With Advanced NSCLC Receiving First-Line Bevacizumab Plus Chemotherapy Regimen.

Nan Geng et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.